Encorafenib and Binimetinib Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain

NCT03898908 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Melanoma
Brain Metastases

Interventions

DRUG: encorafenib
DRUG: binimetinib
RADIATION: Whole brain radiation therapy
RADIATION: Radiosurgery/stereotactic radiosurgery

Sponsor

Grupo Español Multidisciplinar de Melanoma

Collaborators

[object Object]
[object Object]